MoneyWorks4Me

Ajanta Pharma informs about outcome of board meeting

29 Apr 2016 Evaluate

Ajanta Pharma has informed that the Board of Directors of the Company at its meeting held on April 29, 2016, has transacted and recommended that interim dividend declared at the meeting held on March 09, 2016, be considered as final dividend on the equity shares of the Company for the financial year ended March 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..